Alcon to Launch TOTAL30 as the First-and-Only Monthly Replacement, Water Gradient Contact Lens
11 Août 2021 - 7:00AM
Business Wire
- TOTAL30 delivers the only Water Gradient, reusable lens that
is clinically shown to feel like nothing, even on day 301
- The first breakthrough innovation in the $4 billion reusable
lens segment in years2
- Commercially available in the U.S. beginning in September
2021 and Europe later this year
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated
to helping people see brilliantly, today announced plans to launch
TOTAL30®, the first-and-only monthly replacement, Water Gradient
lens that feels like nothing, even on day 30.1 Using Alcon’s
proprietary Water Gradient material first introduced with DAILIES
TOTAL1® contact lenses, TOTAL30 delivers a premium wearing
experience for reusable contact lens wearers. Reusable lenses
account for an estimated 45% of the $9 billion global contact lens
market.2
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20210810006016/en/
(Photo: Business Wire)
“We are incredibly proud to expand our TOTAL® brand with
TOTAL30, the newest member of the Water Gradient family, designed
for reusable lens wearers,” said Andy Pawson, President and General
Manager of the Global Vision Care Franchise at Alcon. “While daily
disposable contact lenses remain appealing to many lens wearers,
approximately two-thirds of contact lens wearers globally choose
reusable lenses.3 Despite this preference, innovation within the
reusable lens segment has lagged behind daily disposables over the
past 10 years. Today, we change that by delivering a reusable lens
with a Water Gradient surface that remains durable for a full 30
days to help people see brilliantly.” 4, 5
TOTAL30 lenses are clinically shown to feel like nothing, even
on day 30, giving contact lens wearers an ultimate wearing
experience in a reusable lens.1 Studies show that comfort plays a
critical role in the lens-wearing experience and brand loyalty of
contact lens wearers.6 Alcon capitalized on its proprietary Water
Gradient contact lens material to provide a reusable lens that
approaches 100% water at the surface, so all that touches the eye
is a gentle cushion of moisture.7, 8* Considering many new wearers
start their contact lens journey in a reusable lens, TOTAL30
provides patients with their first introduction to the exceptional
comfort of Water Gradient material.
“In my experience, some reusable contact lens wearers think
discomfort is the norm with lenses and attribute this to the 30-day
wear cycle,” said Pamela Lowe, O.D., Professional Eye Care Center,
Illinois.** “With TOTAL30, I now have a go-to lens for my patients
who prefer reusable lenses and a premium wearing experience all
month long. There is no longer a comfort compromise!”
The reusable, Water Gradient design of TOTAL30 is made possible
by the introduction of new biomimetic CELLIGENT™ Technology.
CELLIGENT combines a biomimetic surface and a unique lens chemistry
to help resist bacteria and lipid deposits. 9-12 The lens features
an inherently lubricious surface that is as soft as the human
cornea.5 The Water Gradient surface of TOTAL30 is durable and
remains intact during a full month of wear with daily cleaning,
disinfecting and storing.4,5 The lens is compatible with all lens
care solutions.
TOTAL30 sphere will be commercially available in the U.S.
beginning in September 2021. In Europe, TOTAL30 will be rolled out
to a limited number of countries in 2021, with full commercial
availability in early 2022.
Please see product instructions for full wear, care and safety
information.
Forward-Looking
Statements
This press release contains “forward-looking statements” within
the meaning of the safe harbor provisions of the United States
Private Securities Litigation Reform Act of 1995. Forward-looking
statements can be identified by words such as: “anticipate,”
“intend,” “commitment,” “look forward,” “maintain,” “plan,” “goal,”
“seek,” “believe,” “project,” “estimate,” “expect,” “strategy,”
“future,” “likely,” “may,” “should,” “will” and similar references
to future periods.
Forward-looking statements are neither historical facts nor
assurances of future performance. Instead, they are based only on
our current beliefs, expectations and assumptions regarding the
future of our business, future plans and strategies, and other
future conditions. Because forward-looking statements relate to the
future, they are subject to inherent uncertainties and risks that
are difficult to predict. Some of these factors are discussed in
our filings with the United States Securities and Exchange
Commission, including our Form 20-F. Should one or more of these
uncertainties or risks materialize, or should underlying
assumptions prove incorrect, actual results may vary materially
from those anticipated. Therefore, you should not rely on any of
these forward-looking statements.
Forward-looking statements in this press release speak only as
of the date they are made, and we assume no obligation to update
forward-looking statements as a result of new information, future
events or otherwise.
About Alcon
Alcon helps people see brilliantly. As the global leader in eye
care with a heritage spanning more than seven decades, we offer the
broadest portfolio of products to enhance sight and improve
people’s lives. Our Surgical and Vision Care products touch the
lives of more than 260 million people in over 140 countries each
year living with conditions like cataracts, glaucoma, retinal
diseases and refractive errors. Our more than 23,000 associates are
enhancing the quality of life through innovative products,
partnerships with eye care professionals and programs that advance
access to quality eye care. Learn more at www.alcon.com.
*Based on in vitro measurements of unworn lenses.
**Dr. Lowe is a paid Alcon consultant.
References
- In a clinical study wherein patients (n=66) used CLEAR CARE®
solution for nightly cleaning, disinfecting, and storing; Alcon
data on file, 2021.
- Internal Estimates.
- Internal Estimates.
- Surface property analysis of lehfilcon A lenses out of pack and
after 30 days of wear; Alcon data on file, 2020.
- Surface observations of lehfilcon A contact lens and human
cornea using scanning transmissions electron microscopy; Alcon data
on file, 2020.
- Schnider C. Evaluating Monthly Replacement CL Patient
Satisfaction. Abstract and lecture presented at the American
Academy of Optometry Conference 2016, Orlando, FL.
- In vitro analysis of lehfilcon A contact lenses outermost
surface softness and correlation with water content; Alcon data on
file, 2021.
- In vitro analysis of lens oxygen permeability, water content,
and surface imaging; Alcon data on file, 2021.
- Ishihara K, Fukazawa K, Sharma V, Liang S, et al. Antifouling
silicone hydrogel contact lenses with a bioinspired
2-methacryloyloxyethyl phosphorylcholine polymer surface. ACS
Omega. 2021;6:7058-7067.
- In vitro evaluation of bacterial adherence in commercial
lenses: Alcon data on file, 2020.
- In vitro evaluation of bacterial biofilm in commercial lenses:
Alcon data on file, 2020.
- In vitro evaluation of lipid deposition for lehfilcon A and
commercial lenses using 3D confocal imaging; Alcon data on file,
2021.
Connect with us on
Facebook LinkedIn
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210810006016/en/
Investor Relations Christina
Cheng + 41 589 112 110 (Geneva) + 1 817 615 2789 (Fort Worth)
investor.relations@alcon.com
Media Relations Steven Smith
+ 41 589 112 111 (Geneva) + 1 817 551 8057 (Fort Worth)
globalmedia.relations@alcon.com
Alcon (NYSE:ALC)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Alcon (NYSE:ALC)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024